Evogene LtdNASDAQ:EVGN
- LAST PRICE1.9700
- TODAY'S CHANGE (%)-0.1200 (-5.7416%)
- Bid / Lots1.9600/ 1
- Ask / Lots2.0100/ 3
- Open / Previous Close2.0900 / 2.0900
- Day Range
- 52 Week Range
- Volume228,173
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | EVGN |
|---|---|---|
| 09:32 ET | 4562 | 2.0945 |
| 09:33 ET | 6570 | 2.0484 |
| 09:35 ET | 550 | 2.04 |
| 09:37 ET | 1479 | 2.06 |
| 09:39 ET | 311 | 2.06 |
| 09:42 ET | 2584 | 2.05 |
| 09:50 ET | 3921 | 2.0201 |
| 09:53 ET | 500 | 2.03 |
| 09:55 ET | 10721 | 2.0001 |
| 09:57 ET | 3029 | 2.0072 |
| 10:02 ET | 300 | 2.02 |
| 10:04 ET | 100 | 2.03 |
| 10:06 ET | 4014 | 2.01 |
| 10:08 ET | 1400 | 2 |
| 10:09 ET | 1350 | 2 |
| 10:11 ET | 16478 | 1.97 |
| 10:13 ET | 1525 | 1.9501 |
| 10:15 ET | 8612 | 1.97 |
| 10:18 ET | 1400 | 1.96 |
| 10:20 ET | 100 | 2.0018 |
| 10:22 ET | 1226 | 1.98 |
| 10:24 ET | 600 | 1.95 |
| 10:27 ET | 200 | 1.9738 |
| 10:29 ET | 1000 | 1.96 |
| 10:33 ET | 200 | 1.95 |
| 10:36 ET | 3450 | 1.92 |
| 10:38 ET | 3100 | 1.905 |
| 10:40 ET | 4739 | 1.91 |
| 10:44 ET | 327 | 1.92 |
| 10:45 ET | 400 | 1.93 |
| 10:47 ET | 6296 | 1.92 |
| 10:49 ET | 11356 | 1.9 |
| 10:51 ET | 5561 | 1.91 |
| 10:54 ET | 582 | 1.92 |
| 10:56 ET | 272 | 1.9 |
| 11:02 ET | 136 | 1.91 |
| 11:03 ET | 2709 | 1.92 |
| 11:12 ET | 2464 | 1.93 |
| 11:21 ET | 2073 | 1.93 |
| 11:23 ET | 100 | 1.9438 |
| 11:30 ET | 1000 | 1.91 |
| 11:34 ET | 7388 | 1.91 |
| 11:39 ET | 1100 | 1.91 |
| 11:41 ET | 2080 | 1.92 |
| 11:48 ET | 100 | 1.9335 |
| 11:50 ET | 1963 | 1.935 |
| 11:54 ET | 2300 | 1.92 |
| 11:56 ET | 400 | 1.9456 |
| 11:57 ET | 714 | 1.9485 |
| 11:59 ET | 440 | 1.95 |
| 12:01 ET | 4192 | 1.9918 |
| 12:06 ET | 605 | 1.9957 |
| 12:08 ET | 500 | 1.99 |
| 12:10 ET | 500 | 1.96 |
| 12:14 ET | 400 | 1.94 |
| 12:15 ET | 100 | 1.98 |
| 12:17 ET | 300 | 1.98 |
| 12:21 ET | 500 | 1.95 |
| 12:24 ET | 1700 | 1.94 |
| 12:26 ET | 2400 | 1.93 |
| 12:28 ET | 2600 | 1.93 |
| 12:30 ET | 1700 | 1.9101 |
| 12:33 ET | 200 | 1.95 |
| 12:37 ET | 500 | 1.9684 |
| 12:39 ET | 1100 | 1.97 |
| 12:42 ET | 1600 | 1.973159 |
| 12:44 ET | 400 | 1.94 |
| 12:51 ET | 500 | 1.949 |
| 12:53 ET | 750 | 1.96 |
| 01:00 ET | 900 | 1.95 |
| 01:04 ET | 2200 | 1.965 |
| 01:06 ET | 300 | 1.97 |
| 01:08 ET | 400 | 1.97 |
| 01:18 ET | 100 | 1.97 |
| 01:20 ET | 3100 | 1.94 |
| 01:27 ET | 2492 | 1.945 |
| 01:29 ET | 100 | 1.95 |
| 01:31 ET | 200 | 1.96 |
| 01:40 ET | 100 | 1.96 |
| 01:44 ET | 200 | 1.96 |
| 01:45 ET | 900 | 1.98 |
| 01:51 ET | 100 | 1.99 |
| 02:00 ET | 6165 | 1.95 |
| 02:02 ET | 300 | 1.955 |
| 02:03 ET | 100 | 1.96 |
| 02:07 ET | 158 | 1.9401 |
| 02:09 ET | 100 | 1.955 |
| 02:14 ET | 600 | 1.97 |
| 02:16 ET | 100 | 1.9694 |
| 02:20 ET | 1700 | 1.98 |
| 02:21 ET | 3600 | 1.9899 |
| 02:23 ET | 3496 | 1.94 |
| 02:25 ET | 100 | 1.97 |
| 02:30 ET | 100 | 1.97 |
| 02:36 ET | 700 | 1.98 |
| 02:38 ET | 473 | 1.98 |
| 02:48 ET | 400 | 1.99 |
| 02:50 ET | 100 | 2 |
| 02:56 ET | 100 | 1.95 |
| 02:57 ET | 300 | 1.97 |
| 03:06 ET | 3100 | 2 |
| 03:08 ET | 531 | 2 |
| 03:17 ET | 100 | 2 |
| 03:24 ET | 1600 | 2 |
| 03:28 ET | 100 | 2.01 |
| 03:32 ET | 6500 | 1.96 |
| 03:33 ET | 750 | 1.97 |
| 03:46 ET | 100 | 1.975 |
| 03:48 ET | 700 | 1.955 |
| 03:50 ET | 800 | 1.97 |
| 03:55 ET | 5500 | 1.96 |
| 03:57 ET | 300 | 1.96 |
| 04:00 ET | 4812 | 1.97 |
Oct 31, 2024
Evogene Announces Collaboration with Google Cloud to Pioneer Generative AI Foundation Model for Novel Small Molecule Design, from 8:00AM ET on Thursday Oct 31, 2024 by Dow Jones
8:00AM ET on Thursday Oct 31, 2024 by Dow Jones
Oct 29, 2024
Oct 8, 2024
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Evogene Ltd | 10.6M | -0.5x | --- |
Kineta Inc | 9.0M | -0.4x | --- |
Redhill Biopharma Ltd | 10.2M | 0.0x | --- |
Plus Therapeutics Inc | 8.0M | -0.4x | --- |
Petros Pharmaceuticals Inc | 3.4M | -0.1x | --- |
COSCIENS Biopharma Inc | 13.8M | -0.4x | --- |
Company Information
Evogene Ltd is an Israel-based company, engaged in leveraging computational biology to design products for life-science-based industries including human health, agriculture, and industrial applications. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.
Contact Information
- Headquarters
- 13 Gad Feinstein Street, Park RehovotREHOVOT, Israel 7638517
- Phone
- ---
- Fax
- ---
Executives
- Independent Chairman of the Board
- Sarit Firon
- President, Chief Executive Officer
- Ofer Haviv
- Chief Financial Officer
- Dorit Kreiner
- Chief Executive Officer of AgPlenus Limited
- Brian Ember
- Chief Executive Officer of Biomica Limited
- Elran Haber
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $10.6M |
|---|---|
Revenue (TTM) | $9.4M |
Shares Outstanding | 5.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.46 |
EPS | $-3.94 |
Book Value | $2.38 |
P/E Ratio | -0.5x |
Price/Sales (TTM) | 1.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -227.27% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
